The Board of Directors approves Rs. 0.01/- dividend
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Shukra Pharmaceuticals, at its meeting on June 4, 2025, recommended a final dividend of Rs. 0.01 (1%) per equity share of Rs. 1 face value for the financial year 2024-25. The dividend is subject to applicable tax deductions and requires approval from shareholders at the upcoming Annual General Meeting. The board also reviewed other routine business matters during the meeting.
This is a token-level dividend (just 1% on face value), signalling very little cash return to shareholders. Retail investors should not expect any meaningful income or price support from this distribution.